Page last updated: 2024-10-28

hydroxyurea and Amyloidosis

hydroxyurea has been researched along with Amyloidosis in 2 studies

Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.

Research Excerpts

ExcerptRelevanceReference
" ACE inhibition and hydroxyurea decrease proteinuria so they may limit progression of chronic kidney disease."3.88Sickle cell disease: a case report of renal amyloidosis. ( Blanco, P; Bugeja, A; Clark, EG; Sood, MM, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bugeja, A1
Blanco, P1
Clark, EG1
Sood, MM1
Morschhauser, F1
Wattel, E1
Pagniez, D1
Lovi, V1
Rose, C1
Bauters, F1
Fenaux, P1

Other Studies

2 other studies available for hydroxyurea and Amyloidosis

ArticleYear
Sickle cell disease: a case report of renal amyloidosis.
    BMC nephrology, 2018, 10-10, Volume: 19, Issue:1

    Topics: Adult; Amyloidosis; Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Antibodies; DNA;

2018
Glomerular injury in chronic myelomonocytic leukemia.
    Leukemia & lymphoma, 1995, Volume: 18, Issue:5-6

    Topics: Aged; Amyloidosis; Etoposide; Female; Humans; Hydroxyurea; Kidney Diseases; Kidney Glomerulus; Leuke

1995